JPRN-UMIN000014168已完成未知
Effect of Sodium-Glucose Cotransporter-2 inhibitor in patients with type 2 daibetes mellitus - Effect of SGLT2 inhibitor in patients with type 2 daibetes mellitus
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 82
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)severe ketosis, diabetic coma 2)severe infection, before operation, severe trauma 3)allergy for the SGLT2 inhibitor 4)type 1 diabetes 5)chronic renal failure, hemodialysis 6)severe anemia 7)reject to informed consent 8)patients judged by the investigator to be ineligible for some other reason
研究者
相似试验
尚未招募
3 期
A clinical trial to study the effect of a drug,dapagliflozin in type 2 diabetic mellitus patient having diabetic macular edemaCTRI/2019/03/017915Postgraduate Institute of Medical Education and Research
尚未招募
4 期
Effects of SGLT2 Inhibitor Therapy on Pancreatic and hepatic fat content in patients of Type 2 Diabetes MellitusCTRI/2019/08/020909ASTRA ZENECA PHARMACEUTICAL INDIA
已完成
1 期
Effects of sodium glucose co-transporter-2 inhibitor on atrial arrhythmia burden in patient with cardiovascular implantable electronic device: a randomized controlled trialAtrial fibrillation in patients with cardiac implantable electronic deviceTCTR20210315003Faculty of Medicine, Chiang Mai University166
已完成
不适用
Effects of sodium-glucose co-transporter 2 inhibitor on metabolic parameters in patients with diabetes mellitusType 2 diabetesJPRN-UMIN000021584agoya University150
已完成
4 期
Effect of SGLT2 inhibitors on heart function in type 2 diabetic patients in south IndiaCTRI/2020/02/023195izams Institute of Medical Sciences